FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

ROSELLINI MICHAEL 		2. Issuer Name and Ticker or Trading Symbol

NEXEON MEDSYSTEMS INC [ NXNN ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
_____ Officer (give title below)      __ X __ Other (specify below)
Shareholder holding over 5%
(Last)          (First)          (Middle)

1910 PACIFIC AVENUE, SUITE 20000 		3. Date of Earliest Transaction (MM/DD/YYYY)

8/24/2017
(Street)

DALLAS, TX 75201
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                  821890   D    
Common Stock                  702000   I   Michael Rosellini ROTH IRA   (1)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants   $1.50   8/24/2017     J   (2)    200000       8/24/2017   8/24/2019   Common Stock   200000   $0   200000   D    

Explanation of Responses:
(1)  Shares held by the Michael Rosellini ROTH IRA. Dr. Rosellini has the sole power to vote and dispose of the shares held by the Michael Rosellini ROTH IRA.
(2)  On August 24, 2017, Nexeon MedSystems Inc (the "Company") entered into a Securities Purchase Agreement ("SPA") and Senior Secured Convertible Promissory Note (the "Note"). As a condition to making the loan pursuant to the SPA and accepting the Note, Dr. Rosellini executed a Personal Guaranty in favor of the lender. For the issuance of the Guaranty by Dr. Rosellini, the Company granted to Dr. Rosellini a two-year warrant for the purchase of 200,000 shares of the Company's Common Stock, at an exercise price of $1.50 per share (the "Warrant"). The exercise price of the Warrant may be adjusted from time to time pursuant to the terms and conditions of the Warrant and the Warrant may be exercised in whole or in part at any time or times during term of the Warrant.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
ROSELLINI MICHAEL
1910 PACIFIC AVENUE, SUITE 20000
DALLAS, TX 75201


Shareholder holding over 5%

Signatures
/s/ Michael Rosellini 10/6/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Nexeon Medsystems (CE) (USOTC:NXNN)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Nexeon Medsystems (CE) Charts.
Nexeon Medsystems (CE) (USOTC:NXNN)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Nexeon Medsystems (CE) Charts.